Other Stories

S. Korea's drug ministry approves clinical trials of COVID-19 vaccine, treatment Updated: 2020-11-24 13:35:16 KST

South Korea's drug ministry has given approval to local drugmakers to go ahead with clinical trials of coronavirus vaccine and treatment candidates.
With that announcement on Tuesday, SK Bioscience said it will conduct a phase one trial of the vaccine candidate "NBP 2001" to evaluate its safety and efficacy in healthy adults.
The vaccine has already been found safe and effective in animal testing.
The drug ministry has also approved a phase two clinical trial of a new COVID-19 treatment by DongWha Pharm.
Reporter :
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.